The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™
Abstract
Polypharmacy is common, and may modify mechanisms of drug-induced liver injury. We examined the effect of these drug–drug interactions on liver safety reports of four drugs highly associated with hepatotoxicity. In the WHO VigiBase™, liver event reports were examined for acetaminophen, isoniazid, valproic acid, and amoxicillin/clavulanic acid. Then, we evaluated the liver event reporting frequency of these 4 drugs in the presence of co-reported medications. Each of the 4 primary drugs was reported as having more than 2000 liver events, and co-reported with more than 600 different medications. Overall, the effect of 2275 co-reported drugs (316 drug classes) on the reporting frequency was analyzed. Decreased liver event reporting frequency was associated with 245 drugs/122 drug classes, including anti-TNFα, opioids, and folic acid. Increased liver event reporting frequency was associated with 170 drugs/82 drug classes; in particular, halogenated hydrocarbons, carboxamides, and bile acid sequestrants. After adjusting for age, gender, and other co-reported drug classes, multiple co-reported drug classes were significantly associated with decreased/increased liver event reporting frequency in a drug-specific/unspecific manner. In conclusion, co-reported medications were associated with changes in the liver event reporting frequency of drugs commonly associated with hepatotoxicity, suggesting that comedications may modify drug hepatic safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concomitant administration of multiple hepatotoxic drugs has also been associated with an increased risk of DILI in several studies.40–43”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
Navarro, V. J., Barnhart, H., Bonkovsky, H. L., Davern, T., Fontana, R. J., Grant, L., Reddy, R. K., Seeff, L. B., Serrano, J., Sherker, A. H., et al. (2014) · Hepatology · doi:10.1002/hep.27317 · Cited by 418
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Morgan, R. E., van Staden, C. J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R. T., Afshari, C. A., & Hamadeh, H. K. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft176 · Cited by 243
Aleo, M. D., Luo, Y., Swiss, R., Bonin, P. D., Potter, D. M., & Will, Y. (2014) · Hepatology · doi:10.1002/hep.27206 · Cited by 215
Research works printed but not linked: 68
- Alisi, 2005, Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosis, Cell. Physiol. Biochem., 15, 69, 10.1159/000083639 · DOI
- Almenoff, 2003, Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting, Pharmacoepidemiol. Drug Saf., 12, 517, 10.1002/pds.885 · DOI
- Almenoff, 2005, Perspectives on the use of data mining in pharmaco-vigilance, Drug Saf., 28, 981, 10.2165/00002018-200528110-00002 · DOI · Paper page
- Argikar, 2009, Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10, Drug Metab. Dispos., 37, 229, 10.1124/dmd.108.022426 · doi:10.1124/dmd.108.022426
- Bjornsson, 2006, Suspected drug-induced liver fatalities reported to the WHO database, Dig. Liver Dis., 38, 33, 10.1016/j.dld.2005.06.004 · DOI · Paper page
- Carayon, 1996, Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage, Blood, 87, 3170, 10.1182/blood.V87.8.3170.bloodjournal8783170 · DOI · Paper page
- Carey, 2008, Inpatient admissions for drug-induced liver injury: results from a single center, Dig. Dis. Sci., 53, 1977, 10.1007/s10620-008-0250-x · DOI
- Caster, 2014, Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance, Eur. J. Clin. Pharmacol., 70, 501, 10.1007/s00228-013-1632-3 · DOI
- Chen, 2014, A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the ‘rule-of-two’ model, Arch. Toxicol., 88, 1439, 10.1007/s00204-014-1276-9 · DOI
- Cheng, 2007, Regulation of hepatic bile acid transporters Ntcp and Bsep expression, Biochem. Pharmacol., 74, 1665, 10.1016/j.bcp.2007.08.014 · DOI
- Cheung, 2007, Use of complementary and alternative therapies in community-dwelling older adults, J. Altern. Complement. Med., 13, 997, 10.1089/acm.2007.0527 · DOI · Paper page
- Cullen, 2010, Time course gene expression using laser capture microscopy-extracted bile ducts, but not hepatic parenchyma, reveals acute alpha-naphthylisothiocyanate toxicity, Toxicol. Pathol., 38, 715, 10.1177/0192623310373774 · doi:10.1177/0192623310373774
- Davit-Spraul, 2010, The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects, Semin. Liver Dis., 30, 134, 10.1055/s-0030-1253223 · DOI · Paper page
- de Abajo, 2004, Acute and clinically relevant drug-induced liver injury: a population based case-control study, Br. J. Clin. Pharmacol., 58, 71, 10.1111/j.1365-2125.2004.02133.x · DOI · Paper page
- DuMouchel, 1999, Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System (with discussion), Am. Stat., 53, 177, 10.1080/00031305.1999.10474456 · DOI · Paper page
- DuMouchel, W., P.D., 2001. Empirical Bayes Screening for Multi-item Associations the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining San Francisco, California Association for Computing Machinery. · DOI · Paper page
- Estes, 2003, High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure, Arch. Surg., 138, 852, 10.1001/archsurg.138.8.852 · DOI · Paper page
- Felix, 1996, The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-l-cysteine. A pulse radiolysis study, Life Sci., 59, 1141, 10.1016/0024-3205(96)00431-6 · DOI
- Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 96, 10.1053/j.gastro.2014.03.045 · DOI · Paper page
- Garcia-Pagan, 1994, Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis, J. Hepatol., 20, 792, 10.1016/S0168-8278(05)80151-5 · doi:10.1016/s0168-8278(05)80151-5
- Gurwitz, 2003, Incidence and preventability of adverse drug events among older persons in the ambulatory setting, JAMA, 289, 1107, 10.1001/jama.289.9.1107 · DOI · Paper page
- Han, 2013, Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria, Trends Pharmacol. Sci., 34, 243, 10.1016/j.tips.2013.01.009 · DOI · Paper page
- Hauben, 2003, A brief primer on automated signal detection, Ann. Pharmacother., 37, 1117, 10.1345/aph.1C515 · doi:10.1345/aph.1c515
- Huang, 2001, Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers, J. Nutr., 131, 33, 10.1093/jn/131.1.33 · DOI · Paper page
- Hubner, 2000, Sodium, hydrogen exchange type 1 and bile ductular secretory activity in the guinea pig, Hepatology, 31, 562, 10.1002/hep.510310303 · DOI
- James, 1993, Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism, Toxicol. Appl. Pharmacol., 118, 159, 10.1006/taap.1993.1021 · doi:10.1006/taap.1993.1021
- Jolley, 2000, Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI, Hepatology, 32, 1309, 10.1053/jhep.2000.19811 · DOI
- Kacevska, 2011, Perspectives on epigenetics and its relevance to adverse drug reactions, Clin. Pharmacol. Ther., 89, 902, 10.1038/clpt.2011.21 · DOI
- Kohane, 2011, Using electronic health records to drive discovery in disease genomics, Nat. Rev. Genet., 12, 417, 10.1038/nrg2999 · DOI · Paper page
- Kozlov, 2010, Effect of estrogen on mitochondrial function and intracellular stress markers in rat liver and kidney following trauma-hemorrhagic shock and prolonged hypotension, Mol. Med., 16, 254, 10.2119/molmed.2009.00184 · DOI
- Kunduzova, 2004, Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion, J. Am. Soc. Nephrol., 15, 2152, 10.1097/01.ASN.0000133563.41148.74 · DOI
- Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
- Law, 2014, DrugBank 4.0: shedding new light on drug metabolism, Nucleic Acids Res., 42, D1091, 10.1093/nar/gkt1068 · DOI · Paper page
- Leitzmann, 2005, Thiazide diuretics and the risk of gallbladder disease requiring surgery in women, Arch. Intern. Med., 165, 567, 10.1001/archinte.165.5.567 · DOI
- Lu, 2012, Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha, Toxicol. Sci., 125, 126, 10.1093/toxsci/kfr266 · DOI
- Lucena, 2006, Determinants of the clinical expression of amoxicillin–clavulanate hepatotoxicity: a prospective series from Spain, Hepatology, 44, 850, 10.1002/hep.21324 · DOI · Paper page
- Lucena, 2011, Susceptibility to amoxicillin–clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles, Gastroenterology, 141, 338, 10.1053/j.gastro.2011.04.001 · DOI · Paper page
- Maes, 2001, The immunoregulatory effects of antidepressants, Hum. Psychopharmacol., 16, 95, 10.1002/hup.191 · DOI · Paper page
- McWhirter, 2013, Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes, Crit. Rev. Oncol. Hematol., 88, 404, 10.1016/j.critrevonc.2013.05.011 · DOI
- Moore, 2007, Serious adverse drug events reported to the Food and Drug Administration, 1998–2005, Arch. Intern. Med., 167, 1752, 10.1001/archinte.167.16.1752 · DOI · Paper page
- Morgan, 2010, Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development, Toxicol. Sci., 118, 485, 10.1093/toxsci/kfq269 · DOI · Paper page
- Murata, 2007, A novel mechanism for drug-induced liver failure: inhibition of histone acetylation by hydralazine derivatives, J. Hepatol., 46, 322, 10.1016/j.jhep.2006.09.017 · DOI
- Oben, 2003, Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury, Hepatology, 38, 664, 10.1053/jhep.2003.50371 · DOI
- Okamoto, 2009, Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases, Clin. Exp. Immunol., 157, 27, 10.1111/j.1365-2249.2009.03958.x · doi:10.1111/j.1365-2249.2009.03958.x
- Perez, 2009, Bile-acid-induced cell injury and protection, World J. Gastroenterol., 15, 1677, 10.3748/wjg.15.1677 · DOI · Paper page
- Peterson, 1998, The opioid–cytokine connection, J. Neuroimmunol., 83, 63, 10.1016/S0165-5728(97)00222-1 · DOI · Paper page
- Pirmohamed, 2004, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, 329, 15, 10.1136/bmj.329.7456.15 · DOI · Paper page
- Poirier, 2003, On the chemical causation of methyl deficiency and its attendant pathologies, Regul. Res. Perspect., 3, 1
- Ramirez, 2013, Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study, Clin. Exp. Allergy, 43, 344, 10.1111/cea.12034 · DOI
- Randall, 1992, Cholelithiasis in infants receiving furosemide: a prospective study of the incidence and one-year follow-up, J. Perinatol., 12, 107
- Romanque, 2011, Thyroid hormone administration induces rat liver nrf2 activation: suppression by N-acetylcysteine pretreatment, Thyroid, 21, 655, 10.1089/thy.2010.0322 · DOI
- Roy, 1996, Effects of opioids on the immune system, Neurochem. Res., 21, 1375, 10.1007/BF02532379 · DOI · Paper page
- Sakatis, 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds, Chem. Res. Toxicol., 25, 2067, 10.1021/tx300075j · DOI
- Senior, 2007, Drug hepatotoxicity from a regulatory perspective, Clin. Liver Dis., 11, 507, 10.1016/j.cld.2007.06.002 · DOI
- Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
- Shimizu, 2007, Protection of estrogens against the progression of chronic liver disease, Hepatol. Res., 37, 239, 10.1111/j.1872-034X.2007.00032.x · DOI
- Stieger, 2000, Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver, Gastroenterology, 118, 422, 10.1016/S0016-5085(00)70224-1 · DOI · Paper page
- Suzuki, 2009, Co-medication with adrenoreceptor antagonists is associated with lower MELD scores at admission in patients with acetaminophen-induced acute liver failure, Gastroenterology, 136, A-810
- Suzuki, 2009, Co-medications modulating liver injury and repair influence clinical outcome of acetaminophen-associated liver injury, Clin. Gastroenterol. Hepatol., 7, 882, 10.1016/j.cgh.2009.03.034 · DOI · Paper page
- Suzuki, 2010, Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work, Drug Saf., 33, 503, 10.2165/11535340-000000000-00000 · DOI · Paper page
- Takikawa, 2009, Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006, Hepatol. Res., 39, 427, 10.1111/j.1872-034X.2008.00486.x · DOI · Paper page
- Tatonetti, 2011, Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels, Clin. Pharmacol. Ther., 90, 133, 10.1038/clpt.2011.83 · DOI · Paper page
- Uetrecht, 2013, Idiosyncratic adverse drug reactions: current concepts, Pharmacol. Rev., 65, 779, 10.1124/pr.113.007450 · DOI · Paper page
- Vacca, 2011, Inhibition of granulocyte migration by tiotropium bromide, Respir. Res., 12, 24, 10.1186/1465-9921-12-24 · DOI
- Wang, 2009, Fenoterol, a beta(2)-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through beta-arrestin-2 in THP-1 cell line, Acta Pharmacol. Sin., 30, 1522, 10.1038/aps.2009.153 · DOI
- Watkins, 2006, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial, JAMA, 296, 87, 10.1001/jama.296.1.87 · DOI · Paper page
- Yazici, 2014, Risk factors for severe or fatal drug-induced liver injury from amoxicillin–clavulanic acid, Hepatol. Res.
- Yu, 2014, High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury, Drug Metab. Dispos., 42, 744, 10.1124/dmd.113.056267 · DOI · Paper page
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationWu, Y., Liu, Z., Wu, L., Chen, M., & Tong, W. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.729834 · Cited by 26
Ortland, I., Mirjalili, M., Kullak-Ublick, G. A., & Peymani, P. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.20503 · Cited by 16
Metadata
- Authors
- Suzuki, A., Yuen, N. A., Ilic, K., Miller, R. T., Reese, M. J., Brown, H. R., Ambroso, J. I., Falls, J. G., & Hunt, C. M.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 72
- Issue
- 3
- Pages
- 481-490
- ISSN
- 0273-2300
- Cited by
- 58
- References
- 7
- Language
- en
- Update notices
- erratum (2015-10-01)
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Center for Research Resources (UL1RR024128)
- National Institutes of Health
- NIH Roadmap for Medical Research
- GSK Academy
- Ministry of Education and Science of Republic of Serbia (172 009)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. https://app.cochat.ai/papers/10.1016/j.yrtph.2015.05.004
- The paper
- Suzuki, A., Yuen, N. A., Ilic, K., Miller, R. T., Reese, M. J., Brown, H. R., Ambroso, J. I., Falls, J. G., & Hunt, C. M. (2015). Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2015.05.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.